Skip to main content

Closed

TECH: Bio-Techne Corporation Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+5.2% / yr

Operating margin12.7%

ROIC4.7%

Financially safe

Strong

Debt / equity0.14×

Interest coverage14.6×

Current ratio4.49×

Valuation

Unrated

P/E ratio101.5×

Dividend yield0.4%

Bio-Techne Corporation

TECHNASDAQ·USD·Closed

Bio-Techne Corporation

TECHNASDAQ·USD·Closed

$72.09

+0.08%

$72.09

+$0.06 (0.08%)

52W Range

99thpctl

Volume

0.80×avg

Mkt Cap

11.29BUSD

P/E

101.5TTM

Div Yield

0.44%ann

52W Range

99thpctl

Volume

0.80×avg

Market Cap

11.29BUSD

P/E Ratio

101.5TTM

Div Yield

0.44%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings